Acute effects of morphine on regional brain levels of acetylcholine in mice and rats. 1976

J P Green, and S D Glick, and A M Crane, and P I Szilagyi

Morphine increased levels of acetylcholine in mouse striatum in a dose-dependent manner, the increase occurring at the lowest dose previously found to produce analgesia and coinciding with the time of peak analgesic effect. Naloxone blocked this increase. After repeated injections of high doses of morphine, no effect was seen. The hippocampus was the only other brain region showing an effect, and this after a high dose. In the rat, morphine (30 and 90 mg/kg) increased striatal acetylcholine levels. At these and lower doses (2.5 mg/kg and 10 mg/kg) the ratios in the striatum of levels of acetylcholine to levels of dopamine were significantly increased. Only at the highest dose did morphine increase the levels of dopamine in the striatum and of acetylcholine in the hippocampus. Morphine did not change the levels of dopamine in the striatum and of acetylcholine in the hippocampus. Morphine did not change the levels of norepinephrine in either the hypothalamus or cortex of the rat.

UI MeSH Term Description Entries
D007031 Hypothalamus Ventral part of the DIENCEPHALON extending from the region of the OPTIC CHIASM to the caudal border of the MAMMILLARY BODIES and forming the inferior and lateral walls of the THIRD VENTRICLE. Lamina Terminalis,Preoptico-Hypothalamic Area,Area, Preoptico-Hypothalamic,Areas, Preoptico-Hypothalamic,Preoptico Hypothalamic Area,Preoptico-Hypothalamic Areas
D009020 Morphine The principal alkaloid in opium and the prototype opiate analgesic and narcotic. Morphine has widespread effects in the central nervous system and on smooth muscle. Morphine Sulfate,Duramorph,MS Contin,Morphia,Morphine Chloride,Morphine Sulfate (2:1), Anhydrous,Morphine Sulfate (2:1), Pentahydrate,Oramorph SR,SDZ 202-250,SDZ202-250,Chloride, Morphine,Contin, MS,SDZ 202 250,SDZ 202250,SDZ202 250,SDZ202250,Sulfate, Morphine
D009270 Naloxone A specific opiate antagonist that has no agonist activity. It is a competitive antagonist at mu, delta, and kappa opioid receptors. MRZ 2593-Br,MRZ-2593,Nalone,Naloxon Curamed,Naloxon-Ratiopharm,Naloxone Abello,Naloxone Hydrobromide,Naloxone Hydrochloride,Naloxone Hydrochloride Dihydride,Naloxone Hydrochloride, (5 beta,9 alpha,13 alpha,14 alpha)-Isomer,Naloxone, (5 beta,9 alpha,13 alpha,14 alpha)-Isomer,Narcan,Narcanti,Abello, Naloxone,Curamed, Naloxon,Dihydride, Naloxone Hydrochloride,Hydrobromide, Naloxone,Hydrochloride Dihydride, Naloxone,Hydrochloride, Naloxone,MRZ 2593,MRZ 2593 Br,MRZ 2593Br,MRZ2593,Naloxon Ratiopharm
D001921 Brain The part of CENTRAL NERVOUS SYSTEM that is contained within the skull (CRANIUM). Arising from the NEURAL TUBE, the embryonic brain is comprised of three major parts including PROSENCEPHALON (the forebrain); MESENCEPHALON (the midbrain); and RHOMBENCEPHALON (the hindbrain). The developed brain consists of CEREBRUM; CEREBELLUM; and other structures in the BRAIN STEM. Encephalon
D001923 Brain Chemistry Changes in the amounts of various chemicals (neurotransmitters, receptors, enzymes, and other metabolites) specific to the area of the central nervous system contained within the head. These are monitored over time, during sensory stimulation, or under different disease states. Chemistry, Brain,Brain Chemistries,Chemistries, Brain
D002540 Cerebral Cortex The thin layer of GRAY MATTER on the surface of the CEREBRAL HEMISPHERES that develops from the TELENCEPHALON and folds into gyri and sulci. It reaches its highest development in humans and is responsible for intellectual faculties and higher mental functions. Allocortex,Archipallium,Cortex Cerebri,Cortical Plate,Paleocortex,Periallocortex,Allocortices,Archipalliums,Cerebral Cortices,Cortex Cerebrus,Cortex, Cerebral,Cortical Plates,Paleocortices,Periallocortices,Plate, Cortical
D003342 Corpus Striatum Striped GRAY MATTER and WHITE MATTER consisting of the NEOSTRIATUM and paleostriatum (GLOBUS PALLIDUS). It is located in front of and lateral to the THALAMUS in each cerebral hemisphere. The gray substance is made up of the CAUDATE NUCLEUS and the lentiform nucleus (the latter consisting of the GLOBUS PALLIDUS and PUTAMEN). The WHITE MATTER is the INTERNAL CAPSULE. Lenticular Nucleus,Lentiform Nucleus,Lentiform Nuclei,Nucleus Lentiformis,Lentiformis, Nucleus,Nuclei, Lentiform,Nucleus, Lenticular,Nucleus, Lentiform,Striatum, Corpus
D004298 Dopamine One of the catecholamine NEUROTRANSMITTERS in the brain. It is derived from TYROSINE and is the precursor to NOREPINEPHRINE and EPINEPHRINE. Dopamine is a major transmitter in the extrapyramidal system of the brain, and important in regulating movement. A family of receptors (RECEPTORS, DOPAMINE) mediate its action. Hydroxytyramine,3,4-Dihydroxyphenethylamine,4-(2-Aminoethyl)-1,2-benzenediol,Dopamine Hydrochloride,Intropin,3,4 Dihydroxyphenethylamine,Hydrochloride, Dopamine
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D005260 Female Females

Related Publications

J P Green, and S D Glick, and A M Crane, and P I Szilagyi
December 1974, Life sciences,
J P Green, and S D Glick, and A M Crane, and P I Szilagyi
December 1970, The Journal of pharmacology and experimental therapeutics,
J P Green, and S D Glick, and A M Crane, and P I Szilagyi
January 1985, Experimental aging research,
J P Green, and S D Glick, and A M Crane, and P I Szilagyi
November 1975, European journal of pharmacology,
J P Green, and S D Glick, and A M Crane, and P I Szilagyi
February 1970, British journal of pharmacology,
J P Green, and S D Glick, and A M Crane, and P I Szilagyi
November 1974, Brain research,
J P Green, and S D Glick, and A M Crane, and P I Szilagyi
April 1977, Psychopharmacology,
J P Green, and S D Glick, and A M Crane, and P I Szilagyi
January 1980, Advances in experimental medicine and biology,
J P Green, and S D Glick, and A M Crane, and P I Szilagyi
July 2000, Journal of toxicology and environmental health. Part A,
J P Green, and S D Glick, and A M Crane, and P I Szilagyi
August 1977, Journal of neurochemistry,
Copied contents to your clipboard!